Biodegradable polymers in chondrogenesis of human articular chondrocytes

Nasreen Banu, Yasmin Banu, Masamune Sakai, Tadahiko Mashino, Toshie Tsuchiya

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The aim of this study was to evaluate the potential role of polyglycolic acid (PGA), poly(glycolic acid-ε-caprolactone) (PGCL), poly(l-lactic acid-glycolic acid) (PLGA), poly(l-lactic acid-ε-caprolactone, 75:25 (w/w)) [P(LA-CL)25], poly-ε-caprolactone (tetrabutoxy titanium) [PCL(Ti)], and fullerene C-60 dimalonic acid (DMA) in cartilage transplants. After 4 weeks of culture of human articular cartilage, the levels of cell proliferation and differentiation and the expression of cartilage-specific matrix genes were estimated. The relationship between cell differentiation and gap junction protein connexin 43 (Cx43) was also evaluated. All materials except PCL(Ti) retained cell proliferation activities similar to the controls. Cell differentiation levels from the highest to the lowest were in the following order: PGA >> PLGA > PGCL > Control = DMSO > P(LA-CL)25 = PCL(Ti) >> fullerene C-60 DMA. Expression of the collagen type II gene was selectively upregulated for PGA, PGCL, and PLGA and slightly increased for P(LA-CL)25 polymers but was downregulated for fullerene C-60 DMA. Aggrecan gene expression was strongest with PGA and was consistently expressed with other matrices, especially with PGCL and PLGA. However, the expression patterns of the connexin 43 gene were different from the former two genes. Multiple regression analysis revealed a high correlation between cartilage proteoglycans production and expression levels of these three genes.

Original languageEnglish
Pages (from-to)184-191
Number of pages8
JournalJournal of Artificial Organs
Volume8
Issue number3
DOIs
Publication statusPublished - 2005 Sep

Fingerprint

glycolic acid
Chondrogenesis
Biodegradable polymers
Chondrocytes
Polymers
Joints
Polyglycolic Acid
Acids
Cartilage
Lactic Acid
Prostaglandins A
Fullerenes
Genes
Lactic acid
Cell Differentiation
Connexin 43
Cell proliferation
Cell Proliferation
Aggrecans
Transplants

Keywords

  • Biodegradable polymers
  • Connexin 43
  • Human articular chondrocytes
  • Matrix gene

ASJC Scopus subject areas

  • Biophysics

Cite this

Biodegradable polymers in chondrogenesis of human articular chondrocytes. / Banu, Nasreen; Banu, Yasmin; Sakai, Masamune; Mashino, Tadahiko; Tsuchiya, Toshie.

In: Journal of Artificial Organs, Vol. 8, No. 3, 09.2005, p. 184-191.

Research output: Contribution to journalArticle

Banu, Nasreen ; Banu, Yasmin ; Sakai, Masamune ; Mashino, Tadahiko ; Tsuchiya, Toshie. / Biodegradable polymers in chondrogenesis of human articular chondrocytes. In: Journal of Artificial Organs. 2005 ; Vol. 8, No. 3. pp. 184-191.
@article{f9e6e74758b2415680f293eb321d9449,
title = "Biodegradable polymers in chondrogenesis of human articular chondrocytes",
abstract = "The aim of this study was to evaluate the potential role of polyglycolic acid (PGA), poly(glycolic acid-ε-caprolactone) (PGCL), poly(l-lactic acid-glycolic acid) (PLGA), poly(l-lactic acid-ε-caprolactone, 75:25 (w/w)) [P(LA-CL)25], poly-ε-caprolactone (tetrabutoxy titanium) [PCL(Ti)], and fullerene C-60 dimalonic acid (DMA) in cartilage transplants. After 4 weeks of culture of human articular cartilage, the levels of cell proliferation and differentiation and the expression of cartilage-specific matrix genes were estimated. The relationship between cell differentiation and gap junction protein connexin 43 (Cx43) was also evaluated. All materials except PCL(Ti) retained cell proliferation activities similar to the controls. Cell differentiation levels from the highest to the lowest were in the following order: PGA >> PLGA > PGCL > Control = DMSO > P(LA-CL)25 = PCL(Ti) >> fullerene C-60 DMA. Expression of the collagen type II gene was selectively upregulated for PGA, PGCL, and PLGA and slightly increased for P(LA-CL)25 polymers but was downregulated for fullerene C-60 DMA. Aggrecan gene expression was strongest with PGA and was consistently expressed with other matrices, especially with PGCL and PLGA. However, the expression patterns of the connexin 43 gene were different from the former two genes. Multiple regression analysis revealed a high correlation between cartilage proteoglycans production and expression levels of these three genes.",
keywords = "Biodegradable polymers, Connexin 43, Human articular chondrocytes, Matrix gene",
author = "Nasreen Banu and Yasmin Banu and Masamune Sakai and Tadahiko Mashino and Toshie Tsuchiya",
year = "2005",
month = "9",
doi = "10.1007/s10047-005-0302-3",
language = "English",
volume = "8",
pages = "184--191",
journal = "Journal of Artificial Organs",
issn = "1434-7229",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Biodegradable polymers in chondrogenesis of human articular chondrocytes

AU - Banu, Nasreen

AU - Banu, Yasmin

AU - Sakai, Masamune

AU - Mashino, Tadahiko

AU - Tsuchiya, Toshie

PY - 2005/9

Y1 - 2005/9

N2 - The aim of this study was to evaluate the potential role of polyglycolic acid (PGA), poly(glycolic acid-ε-caprolactone) (PGCL), poly(l-lactic acid-glycolic acid) (PLGA), poly(l-lactic acid-ε-caprolactone, 75:25 (w/w)) [P(LA-CL)25], poly-ε-caprolactone (tetrabutoxy titanium) [PCL(Ti)], and fullerene C-60 dimalonic acid (DMA) in cartilage transplants. After 4 weeks of culture of human articular cartilage, the levels of cell proliferation and differentiation and the expression of cartilage-specific matrix genes were estimated. The relationship between cell differentiation and gap junction protein connexin 43 (Cx43) was also evaluated. All materials except PCL(Ti) retained cell proliferation activities similar to the controls. Cell differentiation levels from the highest to the lowest were in the following order: PGA >> PLGA > PGCL > Control = DMSO > P(LA-CL)25 = PCL(Ti) >> fullerene C-60 DMA. Expression of the collagen type II gene was selectively upregulated for PGA, PGCL, and PLGA and slightly increased for P(LA-CL)25 polymers but was downregulated for fullerene C-60 DMA. Aggrecan gene expression was strongest with PGA and was consistently expressed with other matrices, especially with PGCL and PLGA. However, the expression patterns of the connexin 43 gene were different from the former two genes. Multiple regression analysis revealed a high correlation between cartilage proteoglycans production and expression levels of these three genes.

AB - The aim of this study was to evaluate the potential role of polyglycolic acid (PGA), poly(glycolic acid-ε-caprolactone) (PGCL), poly(l-lactic acid-glycolic acid) (PLGA), poly(l-lactic acid-ε-caprolactone, 75:25 (w/w)) [P(LA-CL)25], poly-ε-caprolactone (tetrabutoxy titanium) [PCL(Ti)], and fullerene C-60 dimalonic acid (DMA) in cartilage transplants. After 4 weeks of culture of human articular cartilage, the levels of cell proliferation and differentiation and the expression of cartilage-specific matrix genes were estimated. The relationship between cell differentiation and gap junction protein connexin 43 (Cx43) was also evaluated. All materials except PCL(Ti) retained cell proliferation activities similar to the controls. Cell differentiation levels from the highest to the lowest were in the following order: PGA >> PLGA > PGCL > Control = DMSO > P(LA-CL)25 = PCL(Ti) >> fullerene C-60 DMA. Expression of the collagen type II gene was selectively upregulated for PGA, PGCL, and PLGA and slightly increased for P(LA-CL)25 polymers but was downregulated for fullerene C-60 DMA. Aggrecan gene expression was strongest with PGA and was consistently expressed with other matrices, especially with PGCL and PLGA. However, the expression patterns of the connexin 43 gene were different from the former two genes. Multiple regression analysis revealed a high correlation between cartilage proteoglycans production and expression levels of these three genes.

KW - Biodegradable polymers

KW - Connexin 43

KW - Human articular chondrocytes

KW - Matrix gene

UR - http://www.scopus.com/inward/record.url?scp=26844546279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26844546279&partnerID=8YFLogxK

U2 - 10.1007/s10047-005-0302-3

DO - 10.1007/s10047-005-0302-3

M3 - Article

C2 - 16235035

AN - SCOPUS:26844546279

VL - 8

SP - 184

EP - 191

JO - Journal of Artificial Organs

JF - Journal of Artificial Organs

SN - 1434-7229

IS - 3

ER -